Beginning Dec. 1, 2024, we will require notification/prior authorization for the following specialty medications for UnitedHealthcare Community Plan (Medicaid) members in Maryland:
Drug name | HCPCS code (s) |
---|---|
Abecma® (idecabtagene vicleucel) | Q2055 |
Acthar® Gel (repository corticotropin injection) | J0801 |
Adzynma™ (ADAMTS13, recombinant-krhn) | J7171 |
Amondys 45® (casimersen) | J1426 |
Breyanzi® (lisocabtagene maraleucel) | Q2054 |
Carvykti™ (ciltacabtagene autoleucel) | Q2056 |
Cortrophin® Gel (repository corticotropin injection) | J0802 |
Cosentyx® IV (secukinumab) | J3247 |
Elevidys™ (delandistrogene moxeparvovec-rokl) | J1413 |
Elfabrio® (pegunigalsidase alfa-iwxj) | J2508 |
Evkeeza® (evinacumab-dgnb) | J1305 |
Eylea® HD (aflibercept) | J0177 |
Hemgenix™ (etranacogene dezaparvovec-drlb) | J1411 |
Lamzede® (velmanase alfa-tycv) | J0217 |
Omvoh™ (mirikizumab-mrkz) | J2267 |
Pombiliti™ (cipaglucosidase alfa-atga) | J1203 |
Qalsody™ (tofersen) | J1304 |
Roctavian™ (valoctogcogene roxaparvovec-rvox) | J1412 |
Rystiggo™ (rozanolixizumab-noli) | J9333 |
Tecartus® (brexucabtagene autoleucel) | Q2053 |
Veopoz™ (pozelimab-bbfg) | J9376 |
Vyjuvek™ (beremagene geperpavec-svdt) | J3401 |
Vyvgart® (efgartigimod alfa-fcab) | J9332 |
Vyvgart® Hytrulo™ (efgartigimd alfa and hyaluronidase-qvfc) | J9334 |
Zynteglo™ (betibeglogene autotemcel) | J3393 |
You can submit a prior authorization request through the UnitedHealthcare Provider Portal:
Please note: For the following cell and gene therapies, you must contact Optum Transplant Services at 888-805-1802 to submit your prior authorization request:
If we don’t receive a prior authorization request before the date of service, we’ll deny the claim and you won’t be able to balance bill members.
Connect with us through chat 24/7 in the UnitedHealthcare Provider Portal. For additional contact information, visit our Contact us page.
PCA-1-24-02542-Clinical-NN_08162024